SUR1 As a New Therapeutic Target for Pulmonary Arterial Hypertension.

Animals Diazoxide / pharmacology Endothelial Cells Familial Primary Pulmonary Hypertension Monocrotaline Pulmonary Arterial Hypertension / drug therapy Rats
ABCC8 SUR1 nateglinide pulmonary arterial tone

Journal

American journal of respiratory cell and molecular biology
ISSN: 1535-4989
Titre abrégé: Am J Respir Cell Mol Biol
Pays: United States
ID NLM: 8917225

Informations de publication

Date de publication:
05 2022
Historique:
pubmed: 18 2 2022
medline: 4 5 2022
entrez: 17 2 2022
Statut: ppublish

Résumé

Mutations in

Identifiants

DOI: 10.1165/rcmb.2021-0180OC PMID: 35175177
pubmed: 35175177
doi: 10.1165/rcmb.2021-0180OC
doi:

Substances chimiques

Monocrotaline 73077K8HYV
Diazoxide O5CB12L4FN

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

539-554

Commentaires et corrections

Type : CommentIn

Auteurs

Hélène Le Ribeuz (H)

Université Paris-Saclay, School of Medecine, Paris-Saclay University, Paris, France.
INSERM UMR_S 999, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue, Le Plessis-Robinson, France.

Bastien Masson (B)

Université Paris-Saclay, School of Medecine, Paris-Saclay University, Paris, France.
INSERM UMR_S 999, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue, Le Plessis-Robinson, France.

Véronique Capuano (V)

Université Paris-Saclay, School of Medecine, Paris-Saclay University, Paris, France.
INSERM UMR_S 999, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue, Le Plessis-Robinson, France.
Hôptal Marie Lannelongue, Groupe Hospitalier Paris Saint-Joseph, Le Plessis-Robinson, France.

Mary Dutheil (M)

Université Paris-Saclay, School of Medecine, Paris-Saclay University, Paris, France.
INSERM UMR_S 999, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue, Le Plessis-Robinson, France.
Hôptal Marie Lannelongue, Groupe Hospitalier Paris Saint-Joseph, Le Plessis-Robinson, France.

Hans Gooroochurn (H)

Department of Pathology, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue Hospital, 92350 Le Plessis-Robinson, France.

Angèle Boët (A)

Université Paris-Saclay, School of Medecine, Paris-Saclay University, Paris, France.
INSERM UMR_S 999, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue, Le Plessis-Robinson, France.

Maria-Rosa Ghigna (MR)

Université Paris-Saclay, School of Medecine, Paris-Saclay University, Paris, France.
INSERM UMR_S 999, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue, Le Plessis-Robinson, France.
Hôptal Marie Lannelongue, Groupe Hospitalier Paris Saint-Joseph, Le Plessis-Robinson, France.

Vincent De Montpreville (V)

Department of Pathology, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue Hospital, 92350 Le Plessis-Robinson, France.

Barbara Girerd (B)

Université Paris-Saclay, School of Medecine, Paris-Saclay University, Paris, France.
INSERM UMR_S 999, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue, Le Plessis-Robinson, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.

Mélanie Lambert (M)

Université Paris-Saclay, School of Medecine, Paris-Saclay University, Paris, France.
INSERM UMR_S 999, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue, Le Plessis-Robinson, France.

Olaf Mercier (O)

Université Paris-Saclay, School of Medecine, Paris-Saclay University, Paris, France.
INSERM UMR_S 999, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue, Le Plessis-Robinson, France.
Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue Hospital, 92350 Le Plessis-Robinson, France; and.

Wendy K Chung (WK)

Columbia University, New York, New York.

Marc Humbert (M)

Université Paris-Saclay, School of Medecine, Paris-Saclay University, Paris, France.
INSERM UMR_S 999, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue, Le Plessis-Robinson, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
ORCID: 0000-0003-0703-2892

David Montani (D)

Université Paris-Saclay, School of Medecine, Paris-Saclay University, Paris, France.
INSERM UMR_S 999, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue, Le Plessis-Robinson, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
ORCID: 0000-0002-9358-6922

Fabrice Antigny (F)

Université Paris-Saclay, School of Medecine, Paris-Saclay University, Paris, France.
INSERM UMR_S 999, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue, Le Plessis-Robinson, France.
ORCID: 0000-0002-9515-6571

Articles similaires

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Use of organic material provided by an automatic enrichment device by weaner pigs and its influence on tail lesions.

Philipp Heseker, Jeanette Probst, Stefanie Ammer et al.
1.00
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › SUR1 As a New Therapeutic Target for Pulmonary...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Benzothiadiazines › Diazoxide › SUR1 As a New Therapeutic Target for Pulmonary...
questionsmedicales.fr › Cellules › Cellules épithéliales › Cellules endothéliales › SUR1 As a New Therapeutic Target for Pulmonary...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Maladies pulmonaires › Hypertension artérielle pulmonaire primitive familiale › SUR1 As a New Therapeutic Target for Pulmonary...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Alcaloïdes de type pyrrolizidine › Monocrotaline › SUR1 As a New Therapeutic Target for Pulmonary...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Maladies pulmonaires › Hypertension artérielle pulmonaire › SUR1 As a New Therapeutic Target for Pulmonary...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Rats › SUR1 As a New Therapeutic Target for Pulmonary...